Goto

Collaborating Authors

 cemvision


The Download: mysteries of the immunome, and how to choose a climate tech pioneer

MIT Technology Review

How healthy am I? My immunome knows the score. Made up of 1.8 trillion cells and trillions more proteins, metabolites, mRNA, and other biomolecules, every person's immunome is different, and it is constantly changing. It's shaped by everything we have ever been exposed to physically and emotionally, and powerfully influences everything from our vulnerability to viruses and cancer to how well we age to whether we tolerate certain foods better than others. Yet as critical as the immunome is to each of us, it has remained largely beyond the reach of modern medicine. Now, thanks to a slew of new technologies, understanding this vital and mysterious system is within our grasp, paving the way for powerful new tools and tests to help us better assess, diagnose and treat diseases. On Monday, we published our 2025 edition of Climate Tech Companies to Watch .


2025 Climate Tech Companies to Watch: Cemvision and its low-emissions cement

MIT Technology Review

The startup is using waste materials and alternative fuels to make cement, slashing greenhouse gas emissions in a polluting industry. Cement is one of the most used materials on the planet, and the industry emits billions of tons of greenhouse gasses annually. Cemvision wants to use waste materials and alternative fuels to help reduce climate pollution from cement production. Today, making cement requires crushing limestone and heating it to super high temperatures, usually by burning fossil fuels. The chemical reactions also release carbon dioxide pollution. Swedish startup Cemvision made a few key production changes to reduce both emissions and the need to mine new materials.